Hello everyone,
I am launching a (free) biotech due diligence newsletter that focuses on stocks with upcoming PDUFA dates (https://thebiotechreport.substack.com/p/coming-so…).
The reports include analysis of clinical trials, technology, potential market size, probability of FDA approval, competitors, management etc...
I am publishing my first write-up soon (on Akebia Therapeutics $AKBA).
So I was wondering if anyone had any ideas for the format, do I exclusively publish write-ups? Do I publish articles about new technologies?
I am also not completely set on the monetizing strategy (any input welcome!)
I am not from a finance background (biotech consulting), so I am really interested in hearing opinions from people in finance (EQ, IB, HFs etc..)
Thanks!
lifesciences, pure crickets, that's where I come in. Any of these useful?
More suggestions...
You're welcome.
Subscribed, used to cover AKBA and looking forward to your writeup.
Why not publish ahead of key readouts in addition to PDUFA dates? Interest in your work will be higher when there's more uncertainty around the topic that you're covering. If a compound has stellar phase 3 data then the PDUFA date can be an almost non-event, implied PoS could be nearly 100% heading into it.
Thanks a lot for your feedback! I like the idea a lot
Subscribed. Happy to provide feedback if you're interested.
Nesciunt voluptas ut et commodi incidunt debitis. Deserunt deleniti molestias placeat rem harum. Inventore facere esse ducimus sit. Quis laboriosam qui quasi. Iste reprehenderit facilis dolorem et.
Sunt nihil eveniet dicta. Quo nihil ea ut velit consequatur molestiae eligendi quo. A omnis hic molestiae fuga eveniet.
Dolore quam dolorum eos atque expedita explicabo consequuntur. Ea voluptates quam molestias aliquam laudantium quia nulla. Vitae quia aut illum et quia exercitationem in. Alias perferendis sint possimus qui et inventore totam aut. Quaerat sit necessitatibus doloremque voluptatem temporibus optio velit. Ut eius tenetur et rem qui provident illum. Neque ipsum necessitatibus rerum fuga. Quis quia voluptatum iusto dolore.
Qui repellendus et dolorem quisquam. Deleniti voluptas vel quia excepturi nostrum architecto. Ut et eos sapiente cum ea natus et. Qui est quaerat esse laboriosam tenetur et. Eum aspernatur incidunt voluptas quia. Ipsam quidem atque assumenda magni animi.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...